High Volume Stocks for May-3 At The Close

These stocks are posting high volume for today.

Pfizer Inc (PFE) < (PFE) is currently trading at $33.71 + 0.905 (2.76%). Pfizer Inc (PFE) < is +12.18% for the past 30 days, +4.41% year-to-date, and -1.12% over the last 12 months.

Pfizer Inc is a research-based biopharmaceutical company. The Company’s portfolio includes medicines, vaccines and medical devices, as well as many of the consumer healthcare products.

Valeant Pharmaceuticals International Inc (VRX) < (VRX) is currently trading at $35.65 + 3.00 (9.19%). Valeant Pharmaceuticals International Inc (VRX) < is +27.37% for the past 30 days, -64.93% year-to-date, and -83.95% over the last 12 months.

Valeant Pharmaceuticals International Inc is a specialty pharmaceutical and medical device company that develops, manufactures, and markets a range of generic and branded generic pharmaceuticals, over-the-counter products and medical devices.

Apple Inc (AAPL) < (AAPL) is currently trading at $95.30 + 1.66 (1.77%). Apple Inc (AAPL) < is -13.46% for the past 30 days, -9.46% year-to-date, and -26.19% over the last 12 months.

Apple Inc designs, manufactures, & markets mobile communication & media devices, personal computers, & portable digital music players, & sells a variety of related software, services, accessories, networking solutions, & third-party digital content.

Sprint Corporation (S) < (S) is currently trading at $3.67 + 0.175 (5.01%). Sprint Corporation (S) < is +1.10% for the past 30 days, +1.24% year-to-date, and -29.69% over the last 12 months.

Sprint Corp is a communications company offering wireless and wireline communications products and services to individual consumers, businesses, government subscribers and resellers.

Sarepta Therapeutics Inc. (SRPT) < (SRPT) is currently trading at $18.12 + 0.20 (1.12%). Sarepta Therapeutics Inc. (SRPT) < is -9.81% for the past 30 days, -53.03% year-to-date, and +41.61% over the last 12 months.

Sarepta Therapeutics Inc is a biopharmaceutical company focused on the discovery and development of unique RNA-targeted therapeutics for the treatment of rare, infectious and other diseases.

Delta Air Lines Inc. (DE) (DAL) < (DAL) is currently trading at $42.92 + 0.745 (1.77%). Delta Air Lines Inc. (DE) (DAL) < is -8.70% for the past 30 days, -15.34% year-to-date, and -6.00% over the last 12 months.

Delta Air Lines Inc provides scheduled air transportation for passengers and cargo throughout the United States and around the world. The Company’s business segments are airline and refinery.

Mylan NV (MYL) < (MYL) is currently trading at $43.72 + 1.01 (2.36%). Mylan NV (MYL) < is -8.02% for the past 30 days, -19.14% year-to-date, and -40.87% over the last 12 months.

Mylan NV along with its subsidiaries is a pharmaceutical company. The Company develops, licenses, manufactures, markets and distributes generic, branded generic and specialty pharmaceuticals.

Baxalta Inc (BXLT) < (BXLT) is currently trading at $42.27 + 0.13 (0.31%). Baxalta Inc (BXLT) < is +3.58% for the past 30 days, +8.30% year-to-date, and -- over the last 12 months.

Baxalta Inc is engaged in the developing and marketing of biopharmaceuticals. The Company offers biopharmaceuticals for the treatment of hemophilia, bleeding disorders, immune deficiencies, alpha-1 antitrypsin deficiency, and other chronic.

American Airlines Group Inc. (AAL) < (AAL) is currently trading at $34.52 + 0.085 (0.25%). American Airlines Group Inc. (AAL) < is -12.50% for the past 30 days, -18.50% year-to-date, and -29.99% over the last 12 months.

American Airlines Group Inc through its subsidiaries operates in the airline industry. The Company has hubs in Charlotte, Chicago, Dallas/Fort Worth, Los Angeles, Miami, New York City, Philadelphia, Phoenix and Washington, D.C.

AbbVie Inc. (ABBV) < (ABBV) is currently trading at $61.85 + 0.41 (0.67%). AbbVie Inc. (ABBV) < is +7.58% for the past 30 days, +4.41% year-to-date, and -3.96% over the last 12 months.

AbbVie Inc is a research-based biopharmaceutical company. The Company is engaged in the discovery, development, manufacture and sale of a broad line of pharmaceutical products for treating chronic autoimmune diseases, virology and neurological disorders.